drugset
drugset / Trial / NCT05167123

Pulp Capping in Primary Molars Using TheraCal (LC)

NCT05167123 ↗

Phase 4 Completed 40 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized clinical trial that aims to evaluate clinical and radiographic success rates of indirect pulp capping and direct pulp capping in primary molars with reversible pulpitis using a light-cured tri-calcium silicate base material (TheraCal (LC)).

Timeline

Start
2019-09-01
Primary completion
2021-11-30
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Theracal LC Other / unclassified — —

Indications

dental caries pulpitis